Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Bioethics group: Gilead, Sanofi flunk the clinical trial transparency test
BioPharma Dive
Sat, 11/14/15 - 11:30 am
Tags:
clinical trials, clinical trial data, transparency, Gilead Sciences, Sanofi
FDA approves Gilead's hepatitis C drug for expanded use
Yahoo/Reuters
Fri, 11/13/15 - 10:05 am
Tags:
FDA, Gilead Sciences, hepatitis C, Harvoni
Gilead Sciences: New HIV Drug Put To Question
Bidness, ETC
Wed, 11/11/15 - 09:09 pm
Tags:
Gilead Sciences, HIV, Genvoya, elvitegravir, cobicistat, emtricitabine, TAF
One Reason We Think Biotech Has Bottomed
Seeking Alpha
Sun, 11/8/15 - 11:49 am
Tags:
biotech, Allergan, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Horizon Pharma, Insys, Pfizer, Retrophin, Valeant Pharmaceuticals, ZS Pharma
Gilead Sciences: Patent Cliff? What Patent Cliff?
Barron's
Fri, 11/6/15 - 03:22 pm
Tags:
Gilead Sciences, patent cliff, patents, Genvoya
Gilead, AbbVie Asked by U.S. for Hepatitis C Pricing Options
Bloomberg
Thu, 11/5/15 - 08:58 pm
Tags:
Gilead Sciences, AbbVie, drug pricing, hepatitis C
FDA approves Gilead Sciences' HIV drug cocktail
Yahoo/Reuters
Thu, 11/5/15 - 08:25 pm
Tags:
FDA, HIV, Gilead Sciences, Genvoya
Gilead's Sovaldi Tied to Slow Heartbeat in Hepatitis C Patients
Bloomberg
Thu, 11/5/15 - 09:44 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Gilead Sciences, Inc Not Likely To Go For Large M&A: Maxim Group
Bidness, ETC
Tue, 11/3/15 - 09:14 am
Tags:
Gilead Sciences, M&A, Japan, hepatitis C
Gilead Sciences Really Needs M&A
Barron's
Wed, 10/28/15 - 02:52 pm
Tags:
Gilead Sciences, M&A
Gilead Sciences beats Street 3Q forecasts
Yahoo/AP
Tue, 10/27/15 - 09:23 pm
Tags:
Gilead Sciences, earnings
If It Happened To AbbVie, Could It Also Happen To Gilead?
Seeking Alpha
Mon, 10/26/15 - 09:40 pm
Tags:
AbbVie, Gilead Sciences, hepatitis C
Gilead: A Winner On 3 Fronts
Seeking Alpha
Sun, 10/25/15 - 06:28 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C
Analyzing Gilead Sciences’ Research and Development in 3Q15
Yahoo/Market Realist
Sat, 10/24/15 - 03:40 pm
Tags:
Gilead Sciences, R&D
8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
Tags:
AbbVie, Gilead Sciences, Endo International, Synta Pharmaceuticals, Valeant Pharmaceuticals, Relypsa, Repros Therapeutics, Ocular Therapeutix
FDA's Warning Shakes Up Hep C Landscape
Investopedia
Fri, 10/23/15 - 05:08 pm
Tags:
FDA, warnings, hepatitis C, AbbVie, Gilead Sciences, Harvoni, Viekira Pak
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
24/7 Wall St
Fri, 10/23/15 - 11:08 am
Tags:
FDA, Gilead Sciences, AbbVie, hepatitis C, warnings, Viekira Pak, Technivie
Gilead's new HIV drug shows lower side-effects over longer term
Yahoo/Reuters
Thu, 10/22/15 - 09:50 am
Tags:
Gilead Sciences, HIV, side effects, Genvoya
Gilead Provides Update on Investigational Compound, GS-5734, for the Treatment of Ebola Virus Disease
Yahoo
Wed, 10/21/15 - 11:33 am
Tags:
Gilead Sciences, ebola virus, GS-5734
Medicare covered $4.6B in hep C scripts for H1, and Gilead's the big winner
Fierce Biotech
Tue, 10/20/15 - 06:07 pm
Tags:
Medicare, hepatitis C, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.